ArticleCancers2022

Baseline Plasma Tumor DNA (ctDNA) Correlates with PSA Kinetics in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Treated with Abiraterone or Enzalutamide.

Vincenza Conteduca et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.